Global Sepsis Diagnostics Market Report

Global Sepsis Diagnostics Market, By Technology (Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies), By Product (Instruments, Assays and Reagents, Blood Culture Media, and Other Products), By Pathogen (Bacterial Sepsis, Fungal Sepsis, and Other Pathogens), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: July 2021
  • Report ID: BWC21403
  • Available Format: PDF
  • Page: 141

Report Overview

Sepsis, also known as septicemia, is a clinical and medical condition induced by our immune system's attempt to combat infections. It is an extremely serious and potentially fatal condition in which the body releases chemicals to combat an infection, causing inflammation.

Global Sepsis Diagnostics Market- Industry Trends & Forecast Report 2027

The global sepsis diagnostics market was worth USD 540.1 million in the year 2020 and is further projected to reach USD 1.1 billion by the year 2020, growing at a CAGR of 10.5% during the forecast period (2021-2027). Factors such as the rising prevalence of sepsis and other infectious disorders, as well as significant investment and financing for research and development from private institutions, are moving the global sepsis diagnostics market forward. Furthermore, with rising awareness surrounding sepsis through various government initiatives, the global sepsis market is estimated to flourish in the forecast period as well.

Source: BlueWeave Consulting

Global Sepsis Diagnostics Market- Overview

Sepsis, also known as septicemia, is a clinical and medical condition induced by our immune system's attempt to combat infections. It is an extremely serious and potentially fatal condition in which the body releases chemicals to combat an infection, causing inflammation. Sepsis is a very serious condition because the bacterial infection in our body spreads in the bloodstream, which then flows through the entire body affecting the other crucial organs. What’s more, even surgery may be required in some cases to eliminate infection-damaged tissue. Therefore, Sepsis requires urgent medical diagnosis and treatment.

Global Sepsis Diagnostics Market Forecast and Trends

Growth Drivers

Expanding Research and Development in the Sepsis Diagnostics

The investment and funding from the private institutions have fueled the research and development work in sepsis diagnostics very generously. Moreover, with the increasing prevalence of life-threatening diseases such as sepsis, the demand for accurate diagnosis and treatment has grown in recent years. As a result, researchers are constantly working in the same direction, which will benefit the sepsis diagnostic market in the coming years as more hospitals use better diagnosis and treatment techniques for Sepsis. For instance, ExThera Medical, a revolutionary medical device company based in the United States, has developed Seraph 100, a blood purifying device with numerous potential uses, including the treatment of sepsis, which will be examined in a randomized control study. The trial's goal is to see how successful the Seraph is against a range of bloodstream infections that might cause sepsis. The Seraph 100 is the first blood purifying device to be demonstrated to minimize both viral and bacterial counts in the blood, and it has been used on over 300 COVID-19 patients in the United States and Europe since April 2020.

Growing Cases of Hospital-Acquired Diseases

Sepsis is a disease where the immune system of the body tries to fight external elements such as viruses, fungi, bacteria, and so on. These external elements may get into the body through any means and one of those ways is hospital-acquired infections (HAIs), as healthcare facilities are highly exposed to communicable diseases. Sepsis is a kind of HAI that typically occurs following surgery, in individuals with weakened immune systems, or people with chronic health issues. The prevalence of HAIs has increased severalfold with the outbreak of Covid-19 as it is highly communicable and affects the body very swiftly. This factor is playing a crucial role in the growth of the sepsis diagnostics market.

Restraints

Expensive diagnostics tools may hinder the market growth

Several tests are used to detect complications in the body during the diagnosis of sepsis. The tools or technology used in the diagnosis of sepsis are considered high-end medical devices which are quite expensive. Therefore, the adoption of such instruments in the rising number of hospitals, especially in emerging economies is very limited. Moreover, the high cost of devices often hinders several markets and the case is the same with the sepsis diagnostics market as well. However, in the upcoming years, the global sepsis market may overcome this hindrance as a result of favorable government initiatives.

Impact of Covid-19 on Global Sepsis Diagnostics Market

The Covid-19 outbreak boosted the global sepsis diagnostics market tremendously. According to experts, Covid-19 patients are at a higher risk of pneumonia, kidney failure, and sepsis. Since the pandemic, the number of cases of sepsis has climbed severalfold, putting a strain on the healthcare system. A Covid-19 patient's immune system tries to combat the coronavirus by releasing chemicals in the body. As a result, this increases the chances and severity of sepsis, thereby bolstering the demand for sepsis diagnostics worldwide.

Global Sepsis Diagnostics Market - By Technology

Based on technology, the global sepsis diagnostics market is segmented into molecular diagnostics, microbiology, immunoassay, and other technologies. Among these, the molecular diagnostics segment dominates the market and is expected to grow at a higher CAGR in the forecast period as well. The diagnosis of sepsis is still being researched in the medical field; thus, therapy options are limited. One of the recommended approaches for treating sepsis is molecular diagnostics. As a result, it is in high demand in the global sepsis diagnostic market.

Global Sepsis Diagnostics Market - By Product

Based on products, the global sepsis diagnostics market is segmented into instruments, assays and reagents, blood culture media, and other products. Among these, the blood culture media segment held the largest market share in 2020. It is also predicted to increase at a solid CAGR during the forecast period, owing to factors such as its adoption as a standard diagnostic tool for diagnosing sepsis. Blood culture media is also a very cost-effective option when compared to other products. Therefore, it is in high demand and its market is growing profusely across the globe.

Global Sepsis Diagnostics Market - By Pathogen

Based on pathogen types, the global sepsis diagnostics market is divided into bacterial sepsis, fungal sepsis, and other pathogens. Among these, the bacterial sepsis segment registered the highest cases and led the market in the global sepsis diagnostic market. A high percentage of patients suffering from this blood poisoning disease are cases of bacterial sepsis. There are also sub-segments in bacterial sepsis which are; gram-negative bacterial sepsis and gram-positive bacterial sepsis, in which the gram-negative bacterial sepsis dominates the market and is estimated to rise in the forecast period.

Global Sepsis Diagnostics Market - Regional Insights

Geographically, the global sepsis diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among all the regions, North America accounted for the largest market share in the year 2020. This is because it has high consumption for medical devices due to developed healthcare infrastructure and increasing healthcare expenditure. Moreover, the sepsis cases in the American population are rising at a very sharp rate which is fueling the market demand for sepsis diagnostics. Furthermore, the concentration of market players in this region also plays a very crucial role in the market growth.

Source: BlueWeave Consulting

Competitive Landscape

The major market players in the global sepsis diagnostics market are Immunexpress Inc., Response Biomedical Corp., Axis-Shield Diagnostics Ltd., Beckman Coulter, Inc, Nanosphere, Inc., Sysmex Corporation, T2 Biosystems, Inc., F. Hoffmann-LA Roche Ltd, BioMerieux SA, Bruker Corporation, EKF Diagnostics, Thermo Fisher Scientific, T2 Biosystems, Inc., Cytosorbents, Genmark Diagnostics, and other prominent players. The market is dominated by giant players who cover most of the share. Moreover, the key industry players are consistently adopting organic competitive strategies such as partnerships, mergers, acquisitions, etc. to establish their brand and expand their customer base.

Recent Developments

l  In April 2021, CARB-X, a global non-profit company, granted up to USD 3 million to GenomeKey, a Bristol, UK-based diagnostic solutions company for developing and expanding diagnosis for sepsis. According to the contract, GenomeKey is also entitled to an additional USD 6.5 million if any milestone is met.

l  In October 2020, Immunexpress, a US-based molecular diagnostic company launched SeptiCyte, which is capable of running a molecular diagnostic test for sepsis. It offers benefits such as full integration and fast response in the diagnosis of sepsis, which is specially designed for clinicians.

 

Scope of the Report

Attributes

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa

Product Service/Segmentation

By Technology, By Pathogens, By Product, By Region

Key Players

Danaher Corporation, Cube Dx GmbH, Beckman Coulter, Inc, Abbott Laboratories Inc., Immunexpress Inc., Response Biomedical Corp., Axis-Shield Diagnostics Ltd., Beckman Coulter, Inc, Nanosphere, Inc., Sysmex Corporation, T2 Biosystems, Inc., F. Hoffmann-LA Roche Ltd, BioMerieux SA, Bruker Corporation, EKF Diagnostics, Thermo Fisher Scientific, T2 Biosystems, Inc., Cytosorbents, Genmark Diagnostics and other prominent players.

 

By Technology

Ø  Molecular Diagnostics

Ø  Microbiology

Ø  Immunoassay

Ø  Other Technologies

By Product

Ø  Instruments

Ø  Assays And Reagents

Ø  Blood Culture Media

Ø  Other Products

By Pathogen

Ø  Bacterial Sepsis

Gram-Negative Bacterial Sepsis

Gram-Positive Bacterial Sepsis

Ø  Fungal Sepsis

Ø  Other Pathogens

By Region

Ø  North America

Ø  Europe

Ø  Asia-Pacific (APAC)

Ø  Latin America (LATAM)

Ø  Middle-East & Africa (MEA)

 

FAQs:

1. What is the current size of the global sepsis diagnostics market?

Answer: The global sepsis diagnostics market reached USD 540.1 million in 2020.

2. What are the major factors driving the growth of the global sepsis diagnostics market?

Answer: The major factors driving the growth of the global sepsis diagnostics market are; expanding research and development in sepsis diagnostics and growing cases of hospital-acquired diseases

3. Who are the key players in the global sepsis diagnostics market?

Answer: The key players in the global sepsis diagnostics market are: Danaher Corporation, Cube Dx GmbH, Beckman Coulter, Inc, Abbott Laboratories Inc., Immunexpress Inc., Response Biomedical Corp., Axis-Shield Diagnostics Ltd., Beckman Coulter, Inc, Nanosphere, Inc., Sysmex Corporation, T2 Biosystems, Inc., F. Hoffmann-LA Roche Ltd, BioMerieux SA, Bruker Corporation, EKF Diagnostics, Thermo Fisher Scientific, T2 Biosystems, Inc., Cytosorbents, Genmark Diagnostics and other prominent players.

4. Which product segment accounted for the largest share in the global sepsis diagnostics market?

Answer: The blood culture media segment accounted for the largest share in the global sepsis diagnostics market.

5. Which region is at the highest growth rate in the global sepsis diagnostics market?

Answer: North America has the largest share in the global sepsis diagnostics market.